Broadly speaking, the Foreign Corrupt Practices Act prohibits offering or paying anything of value to a foreign official to obtain or retain business. Recent years have seen a boom in FCPA compliance efforts and enforcement attempts as the Department of Justice has proclaimed this...
Published in the Daily Business Review, July 17, 2014 The recent opinion from the U.S. Court of Appeals for the Eleventh Circuit in U.S. v. Quartavious Davis stands at the crossroad of technology and privacy. In Davis, the Eleventh Circuit held that cell site location...
Published in Law360, May 14, 2014 A petition for commutation (reduction) of sentence represents a possible — though difficult — avenue for relief for individuals convicted of crimes who have exhausted their opportunities for appellate remedies. Recent developments, however, provide new reasons for potential commutation...
Published in Law360, March 19, 2014 The U.S. Supreme Court’s 6-3 decision in Kaley v. United States not only undercuts a criminal defendant’s right to counsel, but also solidifies the power of the grand jury. Read the entire article here.
Paul Calli recently wrote a guest blog post for FCPA Professor blog regarding the oral argument before the United States Eleventh Circuit Court of Appeals on the issue of who is considered a “foreign official” for purposes of the Foreign Corrupt Practices Act (“FCPA”)....
This article was originally published on FCPAProfessor.com. Last Friday in Miami, the 11th Circuit Court of Appeals heard oral argument in U.S. v. Joel Esquenazi & Carlos Rodriguez. The issues on appeal did not just relate to the FCPA’s ”foreign official” element, but as to...
The bloggers of Justice Building Blog covered the victory of attorneys Guy Lewis and Michael Tein in the case Miccosukee Tribe of Indians of Florida v. Lewis et al. In their news coverage, they recognized Lewis and Tein’s attorney, Paul Calli. The blog post recognized...
Assistant Attorney General Lanny Breuer once again took to the podium to highlight the DOJ’s FCPA enforcement program. This time the event was the 13th Annual Pharmaceutical Regulatory and Compliance Congress. If you wanted to hear Mr. Breuer speak at the event, you had to...